First Trust Advisors LP Corcept Therapeutics Inc Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

A detailed history of First Trust Advisors LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, First Trust Advisors LP holds 1,318,137 shares of CORT stock, worth $78 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,318,137
Previous 1,521,608 13.37%
Holding current value
$78 Million
Previous $49.4 Million 23.34%
% of portfolio
0.06%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$29.51 - $46.26 $6 Million - $9.41 Million
-203,471 Reduced 13.37%
1,318,137 $61 Million
Q2 2024

Aug 13, 2024
SELL
$22.21 - $34.48 $7.05 Million - $10.9 Million
-317,204 Reduced 17.25%
1,521,608 $49.4 Million
Q1 2024

May 13, 2024
BUY
$21.1 - $27.46 $35.7 Million - $46.5 Million
1,691,804 Added 1150.82%
1,838,812 $46.3 Million
Q4 2023

Feb 13, 2024
BUY
$24.82 - $32.88 $1.53 Million - $2.03 Million
61,826 Added 72.58%
147,008 $4.77 Million
Q3 2023

Nov 13, 2023
BUY
$21.97 - $33.8 $1.56 Million - $2.39 Million
70,840 Added 493.93%
85,182 $2.32 Million
Q2 2023

Aug 14, 2023
SELL
$21.44 - $25.15 $532,462 - $624,600
-24,835 Reduced 63.39%
14,342 $319,000
Q1 2023

May 15, 2023
SELL
$19.2 - $24.47 $2.09 Million - $2.66 Million
-108,741 Reduced 73.51%
39,177 $848,000
Q4 2022

Feb 09, 2023
BUY
$19.95 - $29.96 $1.49 Million - $2.24 Million
74,667 Added 101.93%
147,918 $3 Million
Q3 2022

Nov 14, 2022
SELL
$24.7 - $29.12 $594,479 - $700,860
-24,068 Reduced 24.73%
73,251 $1.88 Million
Q2 2022

Aug 12, 2022
BUY
$17.33 - $25.3 $114,637 - $167,359
6,615 Added 7.29%
97,319 $2.31 Million
Q1 2022

May 13, 2022
BUY
$16.53 - $25.21 $689,086 - $1.05 Million
41,687 Added 85.05%
90,704 $2.04 Million
Q4 2021

Feb 08, 2022
BUY
$17.1 - $23.34 $571,926 - $780,629
33,446 Added 214.8%
49,017 $971,000
Q3 2021

Nov 15, 2021
SELL
$19.68 - $22.53 $1.37 Million - $1.57 Million
-69,480 Reduced 81.69%
15,571 $306,000
Q2 2021

Aug 16, 2021
SELL
$19.97 - $24.43 $2.54 Million - $3.11 Million
-127,267 Reduced 59.94%
85,051 $1.87 Million
Q1 2021

May 14, 2021
BUY
$23.49 - $30.56 $2.69 Million - $3.5 Million
114,586 Added 117.25%
212,318 $5.05 Million
Q4 2020

Feb 02, 2021
SELL
$16.78 - $27.3 $773,725 - $1.26 Million
-46,110 Reduced 32.06%
97,732 $2.56 Million
Q3 2020

Nov 05, 2020
SELL
$12.46 - $19.98 $192,718 - $309,030
-15,467 Reduced 9.71%
143,842 $2.5 Million
Q2 2020

Jul 22, 2020
BUY
$11.0 - $18.26 $1.11 Million - $1.85 Million
101,230 Added 174.3%
159,309 $2.68 Million
Q1 2020

May 06, 2020
SELL
$10.11 - $14.04 $1.92 Million - $2.66 Million
-189,444 Reduced 76.54%
58,079 $691,000
Q4 2019

Feb 03, 2020
BUY
$12.06 - $16.96 $2.39 Million - $3.36 Million
198,126 Added 401.09%
247,523 $3 Million
Q3 2019

Nov 04, 2019
BUY
$10.41 - $14.66 $386,211 - $543,886
37,100 Added 301.7%
49,397 $698,000
Q2 2019

Jul 30, 2019
SELL
$9.78 - $12.76 $1.51 Million - $1.97 Million
-154,534 Reduced 92.63%
12,297 $137,000
Q1 2019

May 09, 2019
BUY
$10.03 - $15.71 $1.67 Million - $2.62 Million
166,831 New
166,831 $1.96 Million
Q4 2018

Feb 07, 2019
SELL
$11.29 - $17.19 $859,259 - $1.31 Million
-76,108 Closed
0 $0
Q3 2018

Oct 25, 2018
BUY
$12.27 - $15.65 $30,135 - $38,436
2,456 Added 3.33%
76,108 $1.07 Million
Q2 2018

Aug 02, 2018
SELL
$15.3 - $19.69 $864,664 - $1.11 Million
-56,514 Reduced 43.42%
73,652 $1.16 Million
Q1 2018

Apr 23, 2018
SELL
$14.59 - $25.5 $264,064 - $461,524
-18,099 Reduced 12.21%
130,166 $2.14 Million
Q4 2017

Feb 08, 2018
SELL
$15.77 - $20.72 $907,516 - $1.19 Million
-57,547 Reduced 27.96%
148,265 $2.68 Million
Q3 2017

Oct 24, 2017
BUY
$12.3 - $19.3 $2.53 Million - $3.97 Million
205,812
205,812 $3.97 Million

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.34B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email